Citalopram 40mg tablets

Pays: Royaume-Uni

Langue: anglais

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ingrédients actifs:

Citalopram hydrobromide

Disponible depuis:

Viatris UK Healthcare Ltd

Code ATC:

N06AB04

DCI (Dénomination commune internationale):

Citalopram hydrobromide

Dosage:

40mg

forme pharmaceutique:

Oral tablet

Mode d'administration:

Oral

classe:

No Controlled Drug Status

Type d'ordonnance:

Valid as a prescribable product

Descriptif du produit:

BNF: 04030300; GTIN: 5016695291765 5016695009018

Notice patient

FERTILITY:
Citalopram has been shown to reduce the quality of
sperm in animal studies. Theoretically, this could affect
fertility,
but impact on human fertility has not been observed as yet.
DRIVING AND USING MACHINES:
Citalopram may have side
effects like dizziness and lack of concentration. You should not
drive or operate machinery if affected
CITALOPRAM TABLETS CONTAIN LACTOSE:
These tablets contain
lactose. If you have been told that you have intolerance to some
sugars, contact your doctor before taking these tablets.
3. HOW TO TAKE CITALOPRAM TABLETS
Always take Citalopram Tablets exactly as your doctor has told
you. You should check with your doctor or pharmacist if you
are not sure.
Swallow the tablets whole. Do not crush them. The tablets can be
taken either in the morning or in the evening, before or after a meal.
The usual oral dose is:
ADULTS
Depression: The usual dose is 20 mg per day. This may be
increased by your doctor to a maximum of 40 mg per day.
Panic Disorder: The starting dose is 10 mg per day for the first
week before increasing the dose to 20-30 mg per day. The dose
may be increased by doctor to a maximum of 40 mg per day.
ELDERLY PATIENTS (ABOVE 65 YEARS OF AGE):
The starting dose
should be decreased to half of the recommended dose, e.g.
10-20 mg per day. Elderly patients should not usually receive
more than 20 mg per day.
CHILDREN AND ADOLESCENTS (< 18 YEARS):
This medicine is not
recommended for children. For further information, please see
section 2,
BEFORE YOU TAKE CITALOPRAM TABLETS
PATIENTS WITH SPECIAL RISKS:
Patients with liver complaints
should not receive more than 20 mg per day.
PATIENTS
WITH
KIDNEY
DISEASE:
No
dosage
adjustment
is
required in mild or moderate kidney impairment. In severe
renal impairment, your doctor may adjust your dose.
HOW AND WHEN TO TAKE CITALOPRAM TABLETS:
Citalopram
Tablets is taken every day as a single daily dose. Citalopram
Tablets can be taken any time of the day with or without food.
Swallow the tablets with a drink of water. Do not chew them
(they

Résumé des caractéristiques du produit

1.
NAME OF THE MEDICINAL PRODUCT
CITALOPRAM 40mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 film-coated_ _tablet contains 49.98 mg citalopram hydrobromide,
equivalent to 40 mg citalopram.
For the full list of excipients, see section 6.1
3
PHARMACEUTICAL FORM
Film-coated tablets
Round, white film-coated tablets with a break-line and diameter of 10
mm.
The tablet can be divided into equal doses.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Treatment of major depressive episodes.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
Following treatment initiation, an antidepressant effect should not be
expected for at least
two weeks. Treatment should continue until the patient has been free
of symptoms for 4-6
months. Citalopram should be withdrawn slowly; it is advised that the
dose is gradually
reduced over 1-2 week periods.
_Paediatric population _
Citalopram should not be used in the treatment of children and
adolescents under the age of
18 years (see section 4.4).
_Adults _
The recommended starting dose is 20 mg per day. If necessary, the dose
can be increased to
a maximum of 40 mg per day, depending on the individual response of
the patient.
_Elderly patients (>65 years of age) _
For elderly patients the dose should be decreased to half of the
recommended dose, e.g. 10-
20 mg daily. Depending on the individual response of the patient, the
dose can be increased.
The recommended maximum dose for the elderly is 20 mg daily.
_Reduced renal function _
Dosage adjustment is not required if the patient has mild to moderate
renal impairment.
Caution is advised in patients with severe renal impairment
(creatinine clearance less than
30ml/min, see section 5.2).
_Reduced hepatic function _
An initial dose of 10 mg daily for the first two weeks of treatment is
recommended in
patients with mild or moderate hepatic impairment. Depending on
individual patient
response, the dose may be increased to a maximum of 20 mg daily.
Caution and extra
careful dose titration is advised in patients with severely reduced
hep